Earnings call transcript: Boston Scientific Q3 2025 beats forecasts, stock climbs
PositiveFinancial Markets

Boston Scientific has reported its Q3 2025 earnings, surpassing analysts' forecasts and leading to a notable increase in its stock price. This positive performance highlights the company's strong market position and effective strategies, which are crucial for investors and stakeholders looking for growth in the medical device sector.
— Curated by the World Pulse Now AI Editorial System